Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 4/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 4/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PGK1 | P00558 | 2/20 | 0.38 |
| ▸ | PGK2 | P07205 | 2/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15822585 | 0.98 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| Hydrochloric Acid SCHEMBL15823754 | 0.96 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL21349626 | 0.88 | KMT2A (0.39) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL29131289 | 0.88 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL28643929 | 0.87 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL19221711 | 0.87 | TAS1R3 (0.36) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL28106244 | 0.84 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL21352438 | 0.84 | HPGD (0.36) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL11123471 | 0.83 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2KMT2AHPGD | |
| SCHEMBL28701742 | 0.83 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935289-B1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM GROUP B V (NL) | 2019-06-26 | — | — | EP | disclosed |
| WO-2019113085-A1 | ELECTROCHEMICAL DETECTION SYSTEMS AND COMPONENTS THEREOF | Laxmi Therapeutic Devices, Inc. (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20190170739-A1 | ELECTROCHEMICAL DETECTION SYSTEMS AND COMPONENTS THEREOF | Laxmi Therapeutic Devices, Inc. | 2019-06-06 | — | — | US | disclosed |
| EP-3459957-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM Group B.V. (NL) | 2019-03-27 | — | — | EP | disclosed |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | BASF SE (DE) | 2018-08-07 | — | — | US | disclosed |
| US-20160039851-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2016-02-11 | — | — | US | disclosed |
| EP-2935289-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | BASF SE (DE) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014095724-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039851-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | ARSA, ACSL6, RER1 | TAS1R3 763/4885TAS1R1 588/4885TAS1R2 825/4885 |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | ARSA, RER1, ACSL6 | TAS1R3 778/4885TAS1R1 579/4885TAS1R2 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.